GW & Wade’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$34M Buy
217,026
+1,332
+0.6% +$204K 1.1% 25
2023
Q3
$33.6M Sell
215,694
-4,258
-2% -$703K 1.25% 18
2023
Q2
$36.4M Buy
219,952
+9,567
+5% +$1.54M 1.32% 17
2023
Q1
$32.6M Buy
210,385
+1,987
+1% +$321K 1.25% 18
2022
Q4
$36.8M Buy
208,398
+332
+0.2% +$57.3K 1.51% 15
2022
Q3
$34M Sell
208,066
-13,362
-6% -$2.26M 1.66% 14
2022
Q2
$39.3M Buy
221,428
+14,733
+7% +$2.63M 1.78% 12
2022
Q1
$36.6M Buy
206,695
+260
+0.1% +$44.2K 1.57% 14
2021
Q4
$35.3M Buy
206,435
+3,193
+2% +$523K 1.53% 13
2021
Q3
$32.8M Buy
203,242
+763
+0.4% +$130K 1.56% 12
2021
Q2
$33.4M Sell
202,479
-1,593
-0.8% -$264K 1.6% 12
2021
Q1
$33.5M Buy
204,072
+16,259
+9% +$2.63M 1.78% 12
2020
Q4
$29.6M Buy
187,813
+31,390
+20% +$4.63M 1.8% 11
2020
Q3
$23.3M Buy
156,423
+1,006
+0.6% +$149K 1.78% 11
2020
Q2
$21.9M Sell
155,417
-5,089
-3% -$742K 1.79% 11
2020
Q1
$21M Buy
160,506
+2,231
+1% +$317K 1.98% 10
2019
Q4
$23.1M Buy
158,275
+1,226
+0.8% +$166K 1.77% 12
2019
Q3
$20.3M Buy
157,049
+3,016
+2% +$397K 1.73% 13
2019
Q2
$21.5M Sell
154,033
-1,406
-0.9% -$195K 1.95% 12
2019
Q1
$21.7M Buy
155,439
+1,044
+0.7% +$140K 2.05% 9
2018
Q4
$19.9M Buy
154,395
+2,184
+1% +$305K 2.15% 8
2018
Q3
$21M Buy
152,211
+323
+0.2% +$42.9K 2.23% 8
2018
Q2
$18.4M Buy
151,888
+1,626
+1% +$203K 2.08% 8
2018
Q1
$19.3M Buy
150,262
+4,478
+3% +$605K 2.23% 8
2017
Q4
$20.4M Buy
145,784
+2,527
+2% +$352K 2.34% 8
2017
Q3
$18.6M Buy
143,257
+627
+0.4% +$83.1K 2.26% 8
2017
Q2
$18.9M Buy
142,630
+1,141
+0.8% +$146K 2.39% 8
2017
Q1
$17.6M Buy
141,489
+40,672
+40% +$4.86M 2.31% 8
2016
Q4
$11.6M Sell
100,817
-4,078
-4% -$471K 1.91% 11
2016
Q3
$12.4M Sell
104,895
-997
-0.9% -$121K 2.23% 8
2016
Q2
$12.8M Buy
105,892
+4,916
+5% +$559K 2.2% 6
2016
Q1
$10.9M Buy
100,976
+3,971
+4% +$411K 2.13% 8
2015
Q4
$9.96M Buy
97,005
+5,160
+6% +$519K 2.09% 7
2015
Q3
$8.57M Buy
91,845
+3,320
+4% +$321K 1.9% 7
2015
Q2
$8.63M Sell
88,525
-409
-0.5% -$41K 1.71% 8
2015
Q1
$8.95M Buy
88,934
+28,233
+47% +$2.87M 1.68% 8
2014
Q4
$6.35M Sell
60,701
-387
-0.6% -$40.8K 1.66% 14
2014
Q3
$6.51M Sell
61,088
-195
-0.3% -$20.2K 1.89% 11
2014
Q2
$6.41M Sell
61,283
-678
-1% -$68.5K 1.89% 10
2014
Q1
$6.09M Buy
61,961
+769
+1% +$71.3K 1.97% 9
2013
Q4
$5.61M Sell
61,192
-1,595
-3% -$147K 1.82% 11
2013
Q3
$5.44M Sell
62,787
-117
-0.2% -$10.5K 1.88% 9
2013
Q2
$5.4M Buy
+62,904
New +$5.34M 1.95% 10

Other funds holding JNJ

GW & Wade's JNJ Position: Q4 2023 in Review

GW & Wade increased its Johnson & Johnson (JNJ) stake by 0.62% in Q4 2023, buying an estimated $204K and bringing the position to 217,026 shares worth $34M. The position accounts for 1.1% of the portfolio, ranked #25.

GW & Wade first reported a position in JNJ in Q2 2013 and has held it in 43 quarters since. The position peaked at $39.3M in Q2 2022. 3,868 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

  • GW & Wade held 217,026 shares of Johnson & Johnson worth $34M as of Q4 2023.
  • GW & Wade bought 1,332 Johnson & Johnson shares in Q4 2023, an estimated $204K.
  • Johnson & Johnson made up 1.1% of GW & Wade's portfolio in Q4 2023, its #25 holding.
  • GW & Wade first reported a position in Johnson & Johnson in Q2 2013 and has held it in 43 quarters since.
  • GW & Wade's Johnson & Johnson position peaked at $39.3M in Q2 2022.
  • 3,868 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.